Introduction

A complex virtual pre-exposure prophylaxis (PrEP) MDT clinic was set up to review patients with medical complexities including renal or bone impairment, side effects and intolerances. We reviewed 6 months of data.

Method

A retrospective case note review was conducted of all patients referred to the complex clinic from July 2022-Feb 2023. Data collected included patient demographics, reason for referral, PrEP outcomes and discontinuation rates.

Results

2,521 patients received PrEP over 6 months - 618 referrals were made for 563 (22%) patients; 97% male, median age of 36 years and 75% on daily dosing.

Discussion

Nearly a quarter of patients seen for PrEP required a virtual review due to medical complexities most commonly renal impairment. The clinic has been able to provide more options such as alternative generic brand formulations and CAB, acting as a safety net enabling patients to access and remain on PrEP.